Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q6H
DateTimeSourceHeadlineSymbolCompany
21/02/202518:30UK RegulatoryHofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUPLSE:0Q6HHofseth Biocare Asa
21/02/202504:18UK RegulatoryHofseth Biocare ASA: PRIMARY INSIDER NOTIFICATIONLSE:0Q6HHofseth Biocare Asa
14/02/202518:45UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
13/12/202401:07UK RegulatoryHofseth Biocare ASA: PRIMARY INSIDER NOTIFICATIONLSE:0Q6HHofseth Biocare Asa
05/12/202419:00UK RegulatoryHofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacityLSE:0Q6HHofseth Biocare Asa
08/11/202418:15UK RegulatoryHofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
22/10/202419:55UK RegulatoryHofseth Biocare ASA: CFO RESIGNATIONLSE:0Q6HHofseth Biocare Asa
08/10/202417:45UK RegulatoryHofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENTLSE:0Q6HHofseth Biocare Asa
23/08/202416:00UK RegulatoryHofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
14/08/202421:09UK RegulatoryHofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERYLSE:0Q6HHofseth Biocare Asa
02/07/202417:00UK RegulatoryHofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.LSE:0Q6HHofseth Biocare Asa
11/06/202417:00UK RegulatoryHofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHYLSE:0Q6HHofseth Biocare Asa
16/05/202416:00UK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
10/05/202422:30UK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
19/04/202421:00UK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
19/04/202416:00UK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
06/04/202403:08UK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
21/03/202420:40UK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
14/03/202422:12UK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
09/02/202418:00UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
07/02/202401:56UK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 Showing the most relevant articles for your search:LSE:0Q6H